Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,356.70
-8.60 (-0.63%)
Nov 6, 2025, 2:30 PM IST
Wockhardt Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 29,840 | 30,120 | 27,980 | 26,510 | 32,300 | 27,080 | Upgrade |
Other Revenue | 250 | 230 | 320 | 60 | - | - | Upgrade |
| 30,090 | 30,350 | 28,300 | 26,570 | 32,300 | 27,080 | Upgrade | |
Revenue Growth (YoY) | 0.94% | 7.24% | 6.51% | -17.74% | 19.28% | -4.78% | Upgrade |
Cost of Revenue | 10,960 | 12,090 | 12,320 | 11,720 | 13,490 | 12,100 | Upgrade |
Gross Profit | 19,130 | 18,260 | 15,980 | 14,850 | 18,810 | 14,980 | Upgrade |
Selling, General & Admin | 6,894 | 6,534 | 6,298 | 6,380 | 7,509 | 7,930 | Upgrade |
Other Operating Expenses | 7,626 | 7,526 | 7,662 | 7,390 | 8,321 | 7,660 | Upgrade |
Operating Expenses | 16,690 | 16,230 | 16,190 | 16,280 | 18,300 | 18,050 | Upgrade |
Operating Income | 2,440 | 2,030 | -210 | -1,430 | 510 | -3,070 | Upgrade |
Interest Expense | -2,070 | -2,500 | -2,910 | -2,920 | -2,820 | -2,430 | Upgrade |
Interest & Investment Income | 160 | 160 | 60 | 40 | 60 | 210 | Upgrade |
Currency Exchange Gain (Loss) | 58.6 | -41.4 | 18.6 | 796 | 108.6 | -21.4 | Upgrade |
Other Non Operating Income (Expenses) | -38.6 | -38.6 | -138.6 | -96 | -158.6 | -38.6 | Upgrade |
EBT Excluding Unusual Items | 550 | -390 | -3,180 | -3,610 | -2,300 | -5,350 | Upgrade |
Merger & Restructuring Charges | - | - | - | -130 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -1,310 | 280 | - | 950 | Upgrade |
Asset Writedown | - | - | -140 | - | - | -1,420 | Upgrade |
Other Unusual Items | -740 | 230 | 430 | -2,780 | -1,810 | 140 | Upgrade |
Pretax Income | -190 | -160 | -4,200 | -6,240 | -4,110 | -5,680 | Upgrade |
Income Tax Expense | 320 | 410 | 520 | -30 | -1,320 | -2,710 | Upgrade |
Earnings From Continuing Operations | -510 | -570 | -4,720 | -6,210 | -2,790 | -2,970 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | 9,850 | Upgrade |
Net Income to Company | -510 | -570 | -4,720 | -6,210 | -2,790 | 6,880 | Upgrade |
Minority Interest in Earnings | 280 | 100 | 90 | 620 | 350 | -20 | Upgrade |
Net Income | -230 | -470 | -4,630 | -5,590 | -2,440 | 6,860 | Upgrade |
Net Income to Common | -230 | -470 | -4,630 | -5,590 | -2,440 | 6,860 | Upgrade |
Shares Outstanding (Basic) | 166 | 157 | 144 | 144 | 121 | 120 | Upgrade |
Shares Outstanding (Diluted) | 166 | 157 | 144 | 144 | 121 | 120 | Upgrade |
Shares Change (YoY) | 13.13% | 8.77% | 0.13% | 19.50% | 0.35% | 8.51% | Upgrade |
EPS (Basic) | -1.39 | -3.00 | -32.10 | -38.80 | -20.24 | 57.10 | Upgrade |
EPS (Diluted) | -1.41 | -3.02 | -32.10 | -38.80 | -20.24 | 57.09 | Upgrade |
Free Cash Flow | 190 | -1,160 | 1,600 | 1,110 | 2,950 | -3,680 | Upgrade |
Free Cash Flow Per Share | 1.15 | -7.39 | 11.09 | 7.71 | 24.47 | -30.63 | Upgrade |
Gross Margin | 63.58% | 60.16% | 56.47% | 55.89% | 58.24% | 55.32% | Upgrade |
Operating Margin | 8.11% | 6.69% | -0.74% | -5.38% | 1.58% | -11.34% | Upgrade |
Profit Margin | -0.76% | -1.55% | -16.36% | -21.04% | -7.55% | 25.33% | Upgrade |
Free Cash Flow Margin | 0.63% | -3.82% | 5.65% | 4.18% | 9.13% | -13.59% | Upgrade |
EBITDA | 4,010 | 3,600 | 1,380 | 420 | 2,260 | -1,430 | Upgrade |
EBITDA Margin | 13.33% | 11.86% | 4.88% | 1.58% | 7.00% | -5.28% | Upgrade |
D&A For EBITDA | 1,570 | 1,570 | 1,590 | 1,850 | 1,750 | 1,640 | Upgrade |
EBIT | 2,440 | 2,030 | -210 | -1,430 | 510 | -3,070 | Upgrade |
EBIT Margin | 8.11% | 6.69% | -0.74% | -5.38% | 1.58% | -11.34% | Upgrade |
Revenue as Reported | 30,480 | 30,740 | 28,810 | 27,730 | 32,500 | 28,400 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.